CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
administration) to reduce maintenance therapy without loss of asthma control in adolescent and adults with severe asthma..Study det...
Phase 3
Créteil, France and 70 other locations
in patients ≥ 6 to \< 18 years of age with severe eosinophilic asthma, including a well-documented history of asthma exacerbations ...
Phase 3
Paris, France and 111 other locations
To assess the efficacy and safety of tezepelumab in pediatric participants with severe uncontrolled asthma on medium to high-dose inhaled co...
Phase 3
Paris, France and 141 other locations
The main objective of this study is to evaluate efficacy and safety of patient's learning in self-taking of prescribed asthma maintenance tr...
Paris, France and 12 other locations
This study evaluates the efficacy and safety of benralizumab as an add-on therapy in uncontrolled eosinophilic asthma participants treated w...
Phase 3
Suresnes, France and 148 other locations
treatment in children 2 to \<6 years of age with uncontrolled asthma and/or recurrent severe asthmatic wheeze. The study will be conducted i...
Phase 3
Paris, France and 75 other locations
levels compared with placebo in participants with moderate-to-severe asthma.Study participation will last approximately 65 weeks, including ...
Phase 2
Paris, France and 120 other locations
treatments in patients undergoing pulmonary care for asthma and/or COPD, who are receiving treatment with Innovair® or Trimbow®. These two ...
Paris, France and 4 other locations
phase IIb study designed to assess efficacy and safety of tozorakimab administered subcutaneously in adult participants with uncontrolled asthma...
Phase 2
Suresnes, France and 206 other locations
Asthma is a common pathology, with a prevalence of 6 to 8% and more than 4 million patients in France. Its management is based on different ...
Phase 4
Paris, France and 7 other locations
Clinical trials
Research sites
Resources
Legal